Emanuel Della-Torre (Emanuel Della Torre)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 15

Top Topics

Community Acquired Pneumonia

Respiratory Syndrome Coronavirus

Systemic Lupus Erythematosus

Pulmonary Fibrosis

Top Venues

Annals of the rheumatic diseases

Journal of scleroderma and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Sabrina Gloria Giulia Testoni, Claudia Minici, Elisa Benetti, Francesca Clemente, Daniela Boselli, Clara Sciorati, Lucia De Monte, Maria Chiara Petrone, Markus Enderle, Walter Linzenbold, Maria Pia Protti, Angelo Manfredi, Francesco De Cobelli, Michele Reni, Massimo Falconi, Gabriele Capurso, Paolo Giorgio Arcidiacono, Emanuel Della-Torre
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma. Cancers 15 (14) (2023)
Sara Nikolic, Marco Lanzillotta, Nikola Panic, Torkel B Brismar, Carlos Fernandez Moro, Gabriele Capurso, Emanuel Della-Torre, Johannes Matthias Löhr, Miroslav Vujasinovic
Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature. United European gastroenterology journal 10 (5) (2022)
Valentina Cucca, Giuseppe Alvise Ramirez, Patrizia Pignatti, Chiara Asperti, Marco Russo, Emanuel Della-Torre, Daniela Breda, Samuele E Burastero, Lorenzo Dagna, Mona-Rita Yacoub
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study. Nutrients 14 (7) (2022)
Giuseppe Alvise Ramirez, Veronica Batani, Luca Moroni, Giacomo De Luca, Giuseppe Pizzetti, Simone Sala, Giovanni Peretto, Campochiaro Corrado, Emanuel Della-Torre, Enrica P Bozzolo, Lorenzo Dagna
Cardiac Safety of mRNA-Based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis. Pathogens (Basel, Switzerland) 11 (9) (2022)
Silvia Bellando-Randone, Emanuel Della-Torre, Andra Balanescu
The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic? Journal of scleroderma and related disorders 6 (3) (2021)
Giuseppe Alvise Ramirez, Emanuel Della-Torre, Luca Moroni, Mona-Rita Yacoub, Lorenzo Dagna, null null
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Annals of the rheumatic diseases 80 (10) (2021)
Sabrina Gloria Giulia Testoni, Maria Chiara Petrone, Michele Reni, Gemma Rossi, Maurizio Barbera, Valeria Nicoletti, Simone Gusmini, Gianpaolo Balzano, Walter Linzenbold, Markus Enderle, Emanuel Della-Torre, Francesco De Cobelli, Claudio Doglioni, Massimo Falconi, Gabriele Capurso, Paolo Giorgio Arcidiacono
Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial. Cancers 13 (18) (2021)
Samantha Sanders, Xiaoqing Fu, Yuqing Zhang, Cory A Perugino, Rachel Wallwork, Emanuel Della-Torre, Liam Harvey, Tyler Harkness, Aidan Long, Hyon K Choi, John H Stone, Zachary Scott Wallace
Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis care & research (2020)
Giuseppe Alvise Ramirez, Luca Moroni, Emanuel Della-Torre, Maria Gerosa, Lorenzo Beretta, Enrica P Bozzolo, Lorenzo Dagna
Systemic lupus erythematosus and COVID-19: what we know so far. Annals of the rheumatic diseases (2020)
Emanuel Della-Torre, Campochiaro Corrado, Giulio Cavalli, Giacomo De Luca, Fabio Ciceri, Alberto Zangrillo, Lorenzo Dagna
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli. Annals of the rheumatic diseases (2020)
Emanuel Della-Torre, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi
Colchicine treatment in community healthcare setting to prevent severe COVID-19. Annals of the rheumatic diseases (2020)
Emanuel Della-Torre, Marco Lanzillotta, Mona-Rita Yacoub
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. Annals of the rheumatic diseases (2020)
Emanuel Della-Torre, Giovanni Landoni, Alberto Zangrillo, Lorenzo Dagna
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang. Annals of the rheumatic diseases (2020)
Emanuel Della-Torre, Campochiaro Corrado, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, ALberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna, null null, null null
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Annals of the rheumatic diseases 79 (10) (2020)
Marco Lanzillotta, Corrado Campochiaro, Matteo Trimarchi, Gianluigi Arrigoni, Simonetta Gerevini, Raffaella Milani, Enrica Bozzolo, Matteo Biafora, Elena Venturini, Maria Pia Cicalese, John H Stone, Maria Grazia Sabbadini, Emanuel Della-Torre
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. Modern rheumatology 27 (4) (2016)